Finally, intravitreal anti-VEGF agents have been used successfully to treat submacular hemorrhage due to neovascular AMD, proliferative retinopathy and PCV but few cases, related to ocular trauma, have been described. The gene discussed is VEGFA; the disease is retinal disorder.